NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Verge Labs

Verge Labs

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.vergegenomics.com/

Last Round

Strategic

Sep 8, 2023

Est. Valuation

$1.71M

Total Funding Raised

$134.12M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Verge Labs is a biotechnology company that provides drug developers with an AI-powered platform and proprietary patient genomic datasets to identify therapeutic targets for neurodegenerative diseases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Clinical Trials

Business Model

B2B

Customer Profile

Data as a Service, Revenue Share

AI Layer

Infrastructure

Keywords

ai drug discoverydrug discovery platformneurodegenerative diseasebiotech aiin silico drug discoverygenomic data analysistarget identificationpatient stratificationbiomarker identificationals researchparkinson's researchclinical-stage biotechpharma partnershipdata as a servicedaas

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Verge Labs Comparables

Compare Verge Labs with similar companies based on industry and business-model similarity.

Verge Labs comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
1910 Genetics
82%
AcuraStem
82%
Argo Therapeutics
81%

Verge Labs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicSep 8, 2023
Series BDec 16, 2021
StrategicJul 8, 2021
Series AJul 16, 2018
SeedOct 28, 2015
Accelerator
Jul 21, 2015

Key People

Founding team and executive leadership

Alice Zhang

CEO Co-founder

Founding Team

Verge Labs Investors

Notable investors and investment history

Verge Labs investors
InvestorRounds
Slow VenturesSeed
S32Series B
Agent CapitalSeries A
Great Oaks Venture CapitalSeed
Threshold VenturesSeries B
DFJ VenturesSeries A
Lifeforce CapitalSeries B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 23, 2026

    Eli Lilly and AstraZeneca partnerships exceed $1.6B.

  • Feb 23, 2026

    Two unnamed drugs have been delivered to the clinic.

Verge Labs Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Verge Labs Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Verge Labs's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range27
Year Founded2015
Last FundingSep 8, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.